Anesthesia Monitoring and Management

Induction is the transition from awake to asleep, usually performed intravenously in adults using propofol (a lipid emulsion that causes rapid loss of consciousness in 30–60 seconds). Sequence: (1) Pre-oxygenate the patient for 3–5 minutes with 100% oxygen via mask or nasal cannula to fill the lungs with oxygen and create a buffer before apnea occurs (the anesthesiologist's friend in case of difficult intubation); (2) establish IV access (18–20 gauge for general anesthesia); (3) inject the induction agent (propofol 1–2 mg/kg IV) and watch the patient's eyes close and muscle tone diminish; (4) administer a muscle relaxant (succinylcholine, which causes brief paralysis, or rocuronium) to facilitate intubation; (5) wait 30–60 seconds for onset of paralysis; (6) use a laryngoscope (direct or video) to visualize the vocal cords and pass an endotracheal tube (ETT) into the trachea, verifying placement by watching the tube pass between the cords and hearing breath sounds bilaterally, then confirming via capnography (CO2 is present only if the tube is in the trachea); (7) secure the tube (tape or sutures) and connect it to the anesthesia circuit; (8) adjust ventilation settings (rate, tidal volume) based on the patient's physiology. Complications: if the patient is hypoxic before induction (long nil-by-mouth time, obesity, aspiration risk), pre-oxygenation is even more critical. If intubation is difficult (anatomy anomaly, short neck, small mouth opening), be prepared with a difficult airway cart (gum elastic bougie, fiberoptic scope, emergency cricothyrotomy kit). The goal is a smooth induction with no hypoxia, hypotension, or aspiration.

Standard anesthesia monitoring (ASA standards): (1) heart rate and rhythm (ECG); (2) blood pressure (non-invasive automatic cuff, or invasive arterial line for high-risk patients); (3) oxygen saturation via pulse oximetry (SpO2, target >94%); (4) end-tidal CO2 (ETCO2, shows ventilation adequacy and warns of malignant hyperthermia if rising); (5) core temperature (esophageal probe); (6) neuromuscular blockade (train-of-four stimulation to verify paralysis level if muscle relaxants are used); (7) inspired/expired anesthetic gas concentrations. Abnormalities and responses: (1) Hypoxia (SpO2 <94%) — increase inspired oxygen, check tube position and patency, listen for secretions in the airway, perform a chest exam, check for right mainstem intubation (the tube has slipped into the right mainstem bronchus, collapsing the left lung) and reposition if needed; (2) Hypotension (systolic <90 mmHg) — check fluid status, reduce anesthetic agents if possible, give a fluid bolus, consider vasopressors (phenylephrine, norepinephrine); (3) Hypertension or tachycardia (sign of inadequate anesthesia or pain) — deepen anesthesia, check for full bladder or other surgical stimulus; (4) Rising ETCO2 (sign of malignant hyperthermia, CO2 insufflation during laparoscopy, or hypoventilation) — check the ventilator settings, perform a rapid physical exam for muscle rigidity and fever (malignant hyperthermia is a medical emergency requiring immediate termination of surgery and treatment with dantrolene); (5) Arrhythmia — check electrolytes, acid-base status, anesthetic depth, and tube position. Vigilance is constant: a single glance at the monitors every few seconds is the anesthesiologist's job.

Malignant hyperthermia (MH) is a life-threatening pharmacogenetic disorder triggered by certain anesthetic agents (succinylcholine, volatile anesthetics like sevoflurane) in genetically susceptible individuals. Symptoms: muscle rigidity (often the first sign), rapid rise in ETCO2 (CO2 production spikes due to hypermetabolism), tachycardia, hypertension, myoglobinuria (dark urine from muscle breakdown), core temperature rise (a late sign — do not wait for fever to diagnose MH), and rhabdomyolysis. Management (immediate): (1) stop all triggering agents immediately; (2) hyperventilate with 100% oxygen (the highest possible minute ventilation to clear CO2); (3) prepare and administer dantrolene sodium IV (2.5 mg/kg, repeat every 5 minutes if needed up to 10 mg/kg) — dantrolene blocks calcium release in muscle and stops the reaction; (4) cool the patient aggressively: ice packs to groin, axillae, and neck; cold IV fluids; ice-cold saline bladder and stomach irrigation if core temp >39°C; (5) check labs: arterial blood gas (for acidosis), potassium (watch for hyperkalemia from muscle breakdown), myoglobin and CK (confirm rhabdomyolysis), coagulation studies; (6) maintain urine output >200 mL/h with aggressive fluid resuscitation and sodium bicarbonate (urine alkalinization prevents myoglobin precipitation in the kidney); (7) monitor for complications: DIC (disseminated intravascular coagulation), hyperkalemia leading to cardiac arrhythmia (treat with calcium gluconate, insulin-glucose, salbutamol). Malignant hyperthermia is preventable with careful history (ask about family history of unexpected deaths during surgery or anesthesia) and use of a non-triggering anesthetic technique (use propofol for induction, non-volatile agents for maintenance, avoid succinylcholine).

Difficult airway management requires rapid decision-making and a structured approach (ASA Difficult Airway Algorithm). (1) Assessment before induction: review the chart for clues (previous difficult intubation, sleep apnea, obesity, short neck, small mouth opening, large tongue, micrognathia). (2) Optimize positioning: ramped positioning (shoulders elevated, neck extended) to align the oral, pharyngeal, and laryngeal axes and improve visualization. (3) First attempt: direct laryngoscopy with a standard blade — if unsuccessful (Cormack-Lehane grade 3 or 4, meaning the vocal cords are not fully visible), reposition and try once more. (4) If still unsuccessful, move to video laryngoscopy (a camera-tipped scope that allows viewing around anatomical obstacles) — often successful where direct laryngoscopy failed. (5) If video laryngoscopy fails, try alternative techniques: gum elastic bougie (a bendy stylet threaded blindly through the cords, then the ETT is railroaded over it), fiberoptic scope (allows direct visualization and passage of the tube, but takes longer and requires patient cooperation if awake), or lighted stylet (a wand that transilluminates the neck to guide tube placement). (6) If all else fails and the patient cannot be intubated or ventilated (a 'cannot intubate, cannot ventilate' crisis), emergent cricothyrotomy (a surgical airway through the cricothyroid membrane) is performed. The key is never to panic, have a backup plan, and call for help early (summon the most senior anesthesiologist and prepare for an emergency surgical airway).

Fluid management during surgery requires calculation and vigilance. Initial assessment: (1) calculate maintenance fluids based on the patient's weight (4 mL/kg for the first 10 kg, 2 mL/kg for the next 10 kg, 1 mL/kg for each kg above 20 kg); (2) assess ongoing losses: estimated blood loss (use cell counts on the surgical field, weigh sponges — 1 gram = ~1 mL blood), urine output (should be 0.5–1 mL/kg/h), and insensible losses (sweating, evaporation, respiration). (3) Replace with fluids: crystalloids (normal saline, lactated Ringer's) are first-line; colloids (albumin, fresh frozen plasma) or blood products if significant bleeding. (4) Monitor lab values: potassium, sodium, chloride, and acid-base status on arterial blood gas (ABG). (5) Watch for complications: overload (pulmonary edema, hypertension) or under-resuscitation (hypotension, decreased urine output, metabolic acidosis). Special considerations: (a) Hyperkalemia (high K+) is dangerous and causes cardiac arrhythmias — from blood transfusion, patient renal failure, or massive bleeding; treat with insulin-glucose, calcium gluconate, salbutamol, or dialysis. (b) Hyponatremia (low sodium) causes cerebral edema and seizures; correct slowly (1–2 mEq/L per hour) to avoid osmotic myelinolysis. (c) Transfusion is indicated if hemoglobin <7 g/dL in stable patients, or <10 g/dL if the patient is at high cardiac risk; each unit of PRBC increases Hgb by ~1 g/dL. The art is balancing fluid resuscitation to maintain perfusion (adequate urine output, stable BP) without volume overload.

Emergence is the return to consciousness, the mirror image of induction but with different priorities. Sequence: (1) At the end of surgery, stop volatile anesthetic agents (turn off the vaporizer) and increase minute ventilation to clear the anesthetic from the body — volatile anesthetics are eliminated mainly via respiration, so hyperventilation speeds emergence. (2) Reverse neuromuscular blockade if muscle relaxants were used: administer neostigmine (an anticholinesterase that prolongs acetylcholine action, reversing paralysis) plus glycopyrrolate (an anticholinergic to prevent neostigmine's side effects: bradycardia, bronchospasm, increased salivation). Some newer relaxants (rocuronium) can be reversed with sugammadex (a fast, complete reversal). Check train-of-four (electrical stimulation of the nerve) to ensure full recovery of strength (4/4 twitches = fully reversed). (3) Reduce opioid infusion (opioids cause respiratory depression and delayed emergence). (4) Maintain or increase inspired oxygen to ensure SpO2 >94%. (5) As the patient awakens (eyelid movement, grimacing to stimuli), protect the airway: keep the patient's head extended, prepare for extubation (removal of the ETT) once the patient is breathing spontaneously and responding to commands (able to open eyes on command, follow commands, squeeze your hand). (6) Suction the mouth and throat gently to clear secretions. (7) When ready, remove the ETT during a strong breath (the patient coughs and the tube pops out). (8) Transfer to recovery (PACU — post-anesthesia care unit) where the patient is monitored for complications: hypoxia, hypotension, nausea, vomiting, pain, and agitation. Emergence complications: delirium (thrashing, confusion — more common in children and the elderly), laryngospasm (vocal cord closure due to irritation, managed with 100% oxygen and gentle positive pressure, or succinylcholine if severe), and aspiration if the airway is not protected properly.

Aspiration is the inhalation of gastric contents (food, liquid, blood) into the lungs, causing aspiration pneumonia, chemical pneumonitis, and potentially rapid deterioration. Risk factors: full stomach (emergency surgery, inadequate fasting), obesity, pregnancy, GERD, bowel obstruction. Fasting guidelines: NPO (nothing by mouth) 6 hours for solids, 2 hours for clear liquids. Pre-operative assessment: ask about last meal, symptoms of reflux. Management: (1) Rapid sequence intubation (RSI) for high-risk patients — this is a modified sequence designed to minimize the risk of aspiration: (a) pre-oxygenate with 100% oxygen for 3–5 minutes; (b) apply cricoid pressure (Sellick maneuver — press on the cricoid cartilage to compress the esophagus and prevent gastric contents from entering the oropharynx) once the patient loses consciousness; (c) inject induction agent and muscle relaxant; (d) intubate as soon as paralysis is present (do not bag the patient between induction and intubation, which could inflate the stomach); (e) release cricoid pressure only after the ETT is placed and verified in the trachea. (2) Have a suction catheter ready (a large-bore suction in hand, not just nearby). (3) Position the patient supine or slightly left-down to direct any vomit away from the airway. (4) Maintain cuff pressure (inflate the ETT cuff to seal the airway and prevent aspiration). (5) If aspiration occurs (you see food or liquid in the mouth or tube), immediately suction the pharynx and trachea aggressively, increase inspired oxygen, and plan for post-operative bronchoscopy and observation for aspiration pneumonia (fever, infiltrate on chest X-ray, hypoxia developing 12–48 hours after anesthesia).

Local anesthesia (numbing a small area of skin/tissue) and regional anesthesia (blocking a nerve or group of nerves to numb a larger region) reduce or eliminate the need for general anesthesia and opioids, improving pain control and patient recovery. Local: infiltration of lidocaine (1–2% solution) by the surgeon at the incision site, or a local nerve block (e.g., penile block for circumcision, interscalene block for shoulder surgery). Onset in 5–10 minutes, duration 30 min to 4 hours depending on the dose and whether epinephrine is added (epinephrine causes vasoconstriction and prolongs duration). Regional blocks: (a) spinal anesthesia (injection of local anesthetic into the CSF around the spinal cord, causing rapid, complete blockade of the lower body and abdomen, used for cesarean section, lower extremity surgery); (b) epidural anesthesia (catheter placed in the epidural space, allowing continuous infusion of local anesthetic, used for labor, thoracic surgery, or lower-body procedures); (c) peripheral nerve blocks (ultrasound-guided injection of local anesthetic around a specific nerve, e.g., femoral block for knee surgery, brachial plexus block for arm surgery) — allows the patient to stay awake or receive light sedation while the operative area is numb. Advantages: reduced opioid use (less respiratory depression, nausea, constipation post-op), preserved airway reflexes (no intubation needed), better pain control (local/regional anesthesia often provides superior analgesia vs. systemic opioids), and faster recovery (patient wakes alert). Complications: spinal/epidural — hypotension (from vasodilation), headache (post-dural puncture), nerve injury (rare); peripheral block — hematoma, infection, nerve injury (most reversible). Local anesthesia toxicity (overdose of local agent, e.g., lidocaine) causes CNS toxicity (seizures, coma) and cardiac toxicity (arrhythmias, cardiac arrest) — managed with seizure control, hyperventilation, IV lipid emulsion (Intralipid, which sequesters the local anesthetic in the lipid phase), and emergency support (ECMO in severe cases).